HER2 Support Group Forums

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)
-   General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)
-   -   Overall survival data from ImmunoGen's trastuzumab emtansine Phase III trial on breas (https://her2support.org/vbulletin/showthread.php?t=56176)

News 10-02-2012 07:40 AM
Overall survival data from ImmunoGen's trastuzumab emtansine Phase III trial on breas
 
ImmunoGen, Inc., a biopharmaceutical company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of overall survival (OS) data from the trastuzumab emtansine Phase III trial, EMILIA.

More...


All times are GMT -7. The time now is 11:19 PM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021